Physician profile
Ibrahim Habib
NPI 1740589969
$1,404.12
in general payments reported to CMS, 2019-2025
16 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $187 · 2021: $80.77 · 2022: $116 · 2023: $265 · 2024: $134 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512 · Education: $14.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.11 |
| Education | $14.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $330.94 | 2019-2024 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.74 | 2019-2023 | Xifaxan |
| Covidien LP | $121.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $108.92 | 2023-2025 | Dupixent |
| Pfizer INC. | $88.07 | 2019 | |
| Laborie Medical Technologies Corp. | $83.34 | 2023 | |
| Csl Behring | $83.34 | 2019 | |
| Braintree Laboratories, INC. | $77.89 | 2019-2024 | Sutab, Suflave |
| Celltrion USA INC. | $64.17 | 2025 | Vegzelma |
| Abbvie INC. | $48.69 | 2020-2021 | |
| Endogastric Solutions, INC | $40.45 | 2021 | |
| Genzyme Corporation | $36.72 | 2023 | |
| Medtronic, INC. | $33.29 | 2024 | Bravo |
| Janssen Biotech, INC. | $21.79 | 2019 | |
| Mauna Kea Technologies, INC. | $16.92 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Habib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.